Using advanced technology to improve immune system monitoring and profiling
Machine Learning-Assisted Integrated Optofluidic Nanoplasmonic Biosensing for Precision Immune Profiling and Monitoring
This study is working on new technology that uses smart computer tools to quickly check how your immune system is responding, helping doctors better understand and treat conditions like infections, cancer, and autoimmune diseases by analyzing your blood samples.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Auburn University at Auburn NIH-funded |
| Lab location | 1 site (Auburn, UNITED STATES) |
| Project ID | NIH-10842183 on NIH RePORTER |
What this research studies
This research focuses on developing cutting-edge biosensing technologies that utilize machine learning to analyze immune responses in patients. By detecting cytokines—key signaling molecules in the immune system—this project aims to provide rapid and precise insights into various immune-related diseases, including infections, cancers, and autoimmune disorders. The approach involves creating advanced biosensing platforms that can analyze blood samples at a high throughput, enabling better patient care through personalized immune profiling and monitoring.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with autoimmune diseases, allergies, or cancers who require detailed immune profiling.
Not a fit: Patients with stable, non-immune-related conditions may not receive significant benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and timely diagnoses of immune-related conditions, ultimately improving patient outcomes.
How similar studies have performed: Previous research has shown promise in using similar biosensing technologies for immune analysis, indicating a potential for success in this novel approach.
Where this research is happening
Auburn, UNITED STATES
- Auburn University at Auburn — Auburn, United States (Active)
Researchers
- Principal investigator: Chen, Pengyu — Auburn University at Auburn
- Study coordinator: Chen, Pengyu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.